Full text is available at the source.
Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine against Malaria and Anemia in Pregnant Women
Using occasional doses of sulfadoxine-pyrimethamine to prevent malaria and anemia in pregnant women
AI simplified
Abstract
A total of 15.3% of pregnant women using intermittent preventive treatment with sulfadoxine-pyrimethamine had malaria, compared to 44.7% of non-users.
- Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) is associated with a significantly lower prevalence of malaria among pregnant women.
- Anemia prevalence was 58.4% in non-IPTp users versus 22.8% in IPTp users.
- Controlling for other variables, IPTp-SP users had significantly reduced odds of malaria (odds ratio = 0.18) and anemia (odds ratio = 0.20).
- The findings suggest that IPTp-SP may be effective in preventing both malaria and anemia in pregnant women in Ghana.
AI simplified